Employee demand for GLP-1 insurance coverage grows as a factor in job retention
A recent survey indicates that nearly a third of U.S. workers would consider changing employers to secure health insurance coverage for GLP-1 weight-loss medications.
Rising utilization of GLP-1 drugs for weight management is shifting employer-sponsored health benefits into a key competitive differentiator for recruitment and retention. Data from 9amHealth shows that 73% of employees weigh drug coverage when evaluating job offers, with 31% stating they would actively switch companies to obtain such benefits.
The increasing interest follows a broader trend in medication use, with Gallup reporting that the percentage of U.S. adults taking GLP-1s for weight loss rose from 3% in 2024 to 11% by 2026. As these medications become more prevalent, human resources departments face pressure to reconcile the high costs of these drugs against the potential turnover costs associated with less comprehensive benefit packages.
Corporate approaches to the coverage gap vary significantly. Some organizations, such as Bank of America, have committed substantial capital to include these treatments in their health plans. Conversely, other employers are actively limiting or reducing coverage due to the significant financial burden. These conflicting strategies reflect an ongoing industry debate over the long-term role of weight-loss medication in standardized employee wellness programs.